LYCIA THERAPEUTICS
DEAD

Serial Number

90672001

Owner

Lycia Therapeutics, Inc.

Attorney

Connie Ellerbach

Filing Date

Apr 26, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LYCIA THERAPEUTICS Trademark

Serial Number: 90672001

LYCIA THERAPEUTICS is a trademark filed by Lycia Therapeutics, Inc. on April 26, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Lycia Therapeutics, Inc. (4 trademarks)

400 East Jamie Ct., Suite 200
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

April 26, 2021

Registration Date

Not Registered

Published for Opposition

July 26, 2022

Goods & Services

Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 27, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 27, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2025 EXRA
SOU EXTENSION 5 GRANTED
May 1, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 1, 2025 AITU
SOU EXTENSION 5 FILED
Jan 30, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 6, 2024 EXRA
SOU EXTENSION 4 GRANTED
Aug 6, 2024 EX4G
SOU EXTENSION 4 FILED
Aug 6, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 6, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2024 EXRA
SOU EXTENSION 3 GRANTED
Feb 2, 2024 EX3G
SOU EXTENSION 3 FILED
Feb 2, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2023 EXRA
SOU EXTENSION 2 GRANTED
Aug 17, 2023 EX2G
SOU EXTENSION 2 FILED
Aug 17, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 17, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2023 EXRA
SOU EXTENSION 1 GRANTED
Jan 24, 2023 EX1G
SOU EXTENSION 1 FILED
Jan 24, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 24, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 26, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 22, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 22, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 22, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 31, 2021 NWOS
NEW APPLICATION ENTERED
Apr 29, 2021 NWAP